CLINICAL_TRIALS trial_result · 2019-06-26

Clinical Trial Update: A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder [Phase 3]

Phase 3 trial update for Lu AA21004 in major depressive disorder has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-06-26